CSIMarket Company Name, Ticker, Suppliers, else..
 



<< Back to Financial Strength by Company within In Vitro & In Vivo Diagnostic Substances Industry

In Vitro & In Vivo Diagnostic Substances Industry Financial Strength Information

Financial Strength Information & Trends  
 


Category:  


 
In Vitro & In Vivo Diagnostic Substances Industry 4 Q 3 Q 2 Q 1 Q 4 Q
  2024 2024 2024 2024 2023
Quick Ratio (TTM) 0.86 0.87 0.89 0.82 0.67
Quick Ratio Ranking # 6 # 6 # 25 # 18 # 12
Working Capital Ratio (TTM) 2.1 2.14 2.22 2.17 1.88
Working Capital Ratio Ranking # 2 # 8 # 16 # 13 # 13
Working Capital Per Revenue 0.3 0.3 0.3 0.28 0.23
Working Capital Per Revenue Ranking # 33 # 98 # 78 # 89 # 88
Leverage Ratio (TTM) 0.77 0.74 0.74 0.73 0.87
Leverage Ratio Ranking # 7 # 9 # 12 # 9 # 22
Total Debt to Equity (TTM) 0.45 0.43 0.42 0.42 0.49
Total Debt to Equity Ranking # 17 # 17 # 29 # 26 # 28
Interest Coverage (TTM) - 2.6 1.88 1.82 9.45
Interest Coverage Ranking # 21 # 99 # 82 # 90 # 9
Debt Coverage (TTM) - 0.08 0.06 0.07 0.48
Debt Coverage Ranking # 31 # 7 # 94 # 97 # 8

New: More In Vitro & In Vivo Diagnostic Substances Industry historic financial strength information >>

Quick Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the 4 Q 2024, Quick Ratio fell to 0.86 below In Vitro & In Vivo Diagnostic Substances Industry average.



Within Healthcare sector, In Vitro & In Vivo Diagnostic Substances Industry achieved the highest Quick Ratio. Total ranking remained unchanged relative to the quarter before at no. 6.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Quick Ratio Statistics as of 4 Q 2024
High Average Low
1.65 1.19 0.67
2. quarter 2022   4. quarter 2023

Quick Ratio Industry Ranking
Within: No.
Sector # 1
Overall # 6


Other Quick Ratios
Compare Industry's quick ratio to Phh's or S&P Constituent list of In Vitro & In Vivo Diagnostic Substances Industry
Highest Ranking Quick Ratios Lowest Ranking Quick Ratios
Quick Ratios for PHH's Competitors Definiton of Quick Ratio


In Vitro & In Vivo Diagnostic Substances Industry Working Capital Ratio Statistics as of 4 Q 2024
 



Working Capital Ratio Statistics as of 4 Q 2024
High Average Low
3.95 2.27 1.53
4. quarter 2024   4. quarter 2020



Working Capital Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the 4 Q 2024, Working Capital Ratio fell to 2.1 below In Vitro & In Vivo Diagnostic Substances Industry average.



Within Healthcare sector, In Vitro & In Vivo Diagnostic Substances Industry accomplished the highest Working Capital Ratio. Working Capital Ratio total ranking has improved to 2, from total ranking in previous quarter at 8.



Working Capital Ratio Industry Ranking
Within: No.
Sector # 1
Overall # 2

Other Working Capital Ratios
Highest Ranking Working Capital Ratios Lowest Ranking Working Capital Ratios
Compare Industry's Working Capital ratio to Phh's or S&P Constituent list of In Vitro & In Vivo Diagnostic Substances Industry
Working Capital ratios for PHH's Competitors Definiton of Working Capital Ratio

In Vitro & In Vivo Diagnostic Substances Industry Working Capital Per Revenue Statistics as of 4 Q 2024
 
Working Capital Per Revenue Comment
On the trailing twelve months basis Working Capital Per Revenue was unchanged from the previous quarter at 0.3 in the 4 Q 2024



Within Healthcare sector 2 other industries have achieved lower Working Capital Per Revenue. Working Capital Per Revenue total ranking has improved to 33, from total ranking in previous quarter at 98.




Working Capital Per Revenue Statistics as of 4 Q 2024
High Average Low
6.74 1.22 0.23
4. quarter 2021   4. quarter 2023


Working Capital Per Revenue Industry Ranking
Within: No.
Sector # 3
Overall # 33



Other Working Capital Per Revenue
Compare Industry's Working Capital Per Revenue to Phh's or S&P Constituent list of In Vitro & In Vivo Diagnostic Substances Industry
Return On Assets for In Vitro & In Vivo Diagnostic Substances Industry Definiton of Working Capital Per Revenue



In Vitro & In Vivo Diagnostic Substances Industry Leverage Ratio Statistics as of 4 Q 2024
 


Leverage Ratio Statistics as of 4 Q 2024
High Average Low
1.53 0.91 0.47
4. quarter 2020   4. quarter 2024



Leverage Ratio Comment
Despite repayements of liabilities of -0.61%, in 4 Q 2024, Liabilities to Equity ratio detoriated to 0.77, below In Vitro & In Vivo Diagnostic Substances Industry average.



, In Vitro & In Vivo Diagnostic Substances Industry achieved lowest Leverage Ratio.



Leverage Ratio total ranking has improved so far to 7, from overall ranking in the previous quarter at 9.



Leverage Ratio Industry Ranking
Within: No.
Sector # 1
Overall # 7

Other Leverage Ratios
Compare Industry's Leverage ratio to Phh's or S&P Bond Interest rates
Highest Ranking Leverage Ratios Lowest Ranking Leverage Ratios
Leverage Ratios for PHH's Competitors What is Leverage Ratio?


In Vitro & In Vivo Diagnostic Substances Industry Total Debt to Equity Ratio Statistics as of 4 Q 2024
 
Debt to Equity Ratio Comment
Despite debt repayment of -0.03%, in 4 Q 2024 ,Total Debt to Equity detoriated to 0.45 in the 4 Q 2024, above Industry average.



Within Healthcare sector only one Industry has achieved lower Debt to Equity Ratio. Total ranking remained the same like in the preceding quarter at no. 17.




Debt to Equity Ratio Statistics as of 4 Q 2024
High Average Low
0.49 0.29 0.02
4. quarter 2023   1. quarter 2021



Debt to Equity Industry Ranking
Within: No.
Sector # 2
Overall # 17

Other Debt to Equity Ratios
Highest Ranking Debt to Equity Ratios Lowest Ranking Debt to Equity Ratios
Compare Industry's Debt to Equity ratio to Phh's or S&P Definiton of Debt to Equity Ratio

In Vitro & In Vivo Diagnostic Substances Industry Interest Coverage Ratio Statistics as of 4 Q 2024
 


Interest Coverage Ratio Statistics as of 4 Q 2024
High Average Low
18.03 6.05 -28.06
2. quarter 2022   4. quarter 2024

Interest Coverage Ratio Comment
On the trailing twelve months basis



In the Healthcare sector, In Vitro & In Vivo Diagnostic Substances Industry achieved the highest Interest Coverage Ratio. Interest Coverage total ranking has improved so far to 21, from total ranking in previous quarter at 99.



Interest Coverage Ratio Industry Ranking
Within: No.
Sector # 1
Overall # 21

Other Interest Coverage Ratios
Highest Ranking Interest Coverage Ratios Lowest Ranking Interest Coverage Ratios
Compare Industry's Interest Coverage ratio to Phh's or S&P Definiton of Interest Coverage Ratio


In Vitro & In Vivo Diagnostic Substances Industry Debt Coverage Statistics as of 4 Q 2024
 
Debt Coverage Ratio Comment
On the trailing twelve months basis



Looking into Healthcare sector only one Industry has accomplished higher Debt Coverage Ratio. Debt Coverage Ratio total ranking has declined from the preceding period from 7 to 31.




Debt Coverage Statistics as of 4 Q 2024
High Average Low
14.37 -6.85 -72.17
1. quarter 2021   4. quarter 2021



Debt Coverage Industry Ranking
Within: No.
Sector # 2
Overall # 31

Other Debt Coverage Ratios
Highest Ranking Debt Coverage Ratios Lowest Ranking Debt Coverage Ratios
See also In Vitro & In Vivo Diagnostic Substances Industry's Margin Definiton of Debt Coverage Ratio

Date modified: 2025-04-05T03:14:57+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com